{
    "2021-12-05": [
        [
            {
                "time": "2021-12-01",
                "original_text": "U.S. administers 470.3 mln doses of COVID-19 vaccines -CDC",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID-19",
                        "vaccines",
                        "CDC"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Why Moderna Is the Biggest Winner From COVID Boosters So Far",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Winner",
                        "COVID",
                        "Boosters"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Here's Why Merck Lost Nearly $40 Billion in Value During November",
                "features": {
                    "keywords": [
                        "Merck",
                        "Lost",
                        "$40 Billion",
                        "November"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}